This drug wholesaler's transformation is paying off. Here's why the stock still looks attractive
The largest of America's three big drug wholesalers has outperformed the market this year, but is trading at a discount to its five-year median multiple.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.